1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Work status after treatment for breast cancer: A controlled, prospective, longitudinal study of an ethnically diverse cohort
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Eberle, C. E.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab (Nivo) + platinum-doublet chemotherapy (Chemo) vs chemo as first-line (1L) treatment (Tx) for advanced non-small cell lung cancer (NSCLC) with <1% tumor PD-L1 expression: Results from CheckMate 227
    Meeting Abstract

    Borghaei, H.; Hellmann, M. D.; Paz-Ares, L. G.; Ramalingam, S. S.; Reck, M.; O'Byrne, K. J.; Bhagavatheeswaran, P.; Nathan, F. E.; Brahmer, J. R.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of (177)Lu-octreotate efficacy
    Meeting Abstract

    Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I.; Cwikla, J. B.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis
    Meeting Abstract

    BosseĢ, D.; Xie, W.; Ged, Y.; Hahn, A. W.; Bergerot, P. G.; Ho, T. H.; McKay, R. R.; Rose, T. L.; de Velasco, G.; Tannir, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of locoregional recurrence among locally advanced HER2-positive breast cancer treated with modern multimodality therapy
    Meeting Abstract

    Braunstein, L. Z.; Stempel, M.; Zabor, E. C.; Gillespie, E. F.; Khan, A. J.; Cahlon, O.; McCormick, B.; Powell, S. N.; Morrow, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study
    Meeting Abstract

    Biran, N.; Di Capua Siegel, D. S.; Berdeja, J. G.; Raje, N. S.; Cornell, R. F.; Alsina, M.; Kovacsovics, T.; Fang, B.; Kimball, A.; Landgren, C. O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Lorlatinib in patients (Pts) with previously treated ALK(+) advanced non-small cell lung cancer (NSCLC): Updated efficacy and safety
    Meeting Abstract

    Besse, B.; Solomon, B. J.; Felip, E.; Bauer, T. M.; Ou, S. H. I.; Soo, R. A.; Camidge, D. R.; Chiari, R.; Gadgeel, S. M.; Riely, G. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in merkel cell carcinoma patients with clinically detected lymph node metastases; NCT03271372
    Meeting Abstract

    Bhatia, S.; Brohl, A. S.; Brownell, I.; Chandra, S.; Dakhil, S.; Ernstoff, M. S.; Fecher, L. A.; Gooley, T.; Hanna, G. J.; Hibbert, R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases
    Meeting Abstract

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; Zhang, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L)
    Meeting Abstract

    Bauer, T. M.; Gounder, M. M.; Weise, A. M.; Schwartz, G. K.; Carvajal, R. D.; Kumar, P.; Zernovak, O.; Beck, A.; Doyle, J.; Mendell-Harary, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save